If you are looking for online medical obesity treatment in Spain, you have probably tried diets before without sustainable results. That is not your fault: obesity is a chronic disease with a strong biological component, not a failure of willpower.
In this article we explain how a 100% online medical obesity program works, who is eligible, what labs you need, and what follow-up looks like. All based on European EASO 2025 guidelines.
Medical obesity treatment is a clinical, individualized approach supervised by a doctor. Unlike a generic diet, it starts with a complete patient assessment: clinical history, anthropometrics (BMI, waist circumference), comorbidities, lab work and metabolic status.
The EASO 2025 guidelines define obesity as a chronic and progressive disease that requires long-term treatment, similar to hypertension or diabetes. The goal is not just weight loss, but improving metabolic health sustainably.
According to European guidelines, the general eligibility criteria are:
You complete a detailed questionnaire (about 10 minutes) based on the ABCD framework and the Edmonton Obesity Staging System (EOSS). It covers your history, usual medication, comorbidities and health goals.
A doctor reviews your case. In most cases a baseline safety lab panel is requested following the EASO protocol: glucose, HbA1c, lipid profile, liver and kidney function, and TSH. We provide a request form for your health center or private laboratory.
With the results, the doctor builds a comprehensive plan. If you meet clinical criteria, it includes pharmacological treatment (GLP-1 analogs or dual therapies) with a private medical prescription for your pharmacy.
You track your weight, symptoms and side effects from your patient area. The doctor reviews your progress, adjusts the dose and decides with objective criteria (the "5% rule") whether to continue, change or stop treatment.
The therapeutic arsenal includes GLP-1 receptor analogs and dual therapies (such as semaglutide, liraglutide or tirzepatide), as weekly subcutaneous injections or daily oral formulas. These drugs have shown weight loss of up to 20% at 18 months in clinical trials, according to the science of the new GLP-1 analogs.
Prescription is always individualized and never on demand. In many cases only habit changes or other therapeutic strategies are recommended.
Yes, as long as it is carried out by a doctor registered in Spain following telemedicine regulations and European guidelines. TrueWeight is a medical service: we do not advertise specific medications or guarantee specific results, in compliance with Royal Decree 1416/1994 on prescription medication advertising.
At TrueWeight, the initial assessment is free and without obligation. The follow-up program has plans from €35/month, with quarterly and semiannual options. The cost of medication (if applicable) is paid separately at your pharmacy with the medical prescription.
Complete the free medical assessment (10 minutes). A doctor will review your case and tell you if the program is right for you. No obligation.
Start your free assessment →Medical disclaimer: this article is for informational purposes and does not replace a consultation with a healthcare professional. Obesity is a chronic disease that must be evaluated and treated by qualified medical staff. If you have concerns about your health, consult your doctor.